Cytarabine

Cytarabine, also known as cytosine arabinoside (ara-C), is a chemotherapy medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and non-Hodgkin's lymphoma.

 More from Wikipedia

Metrics Summary

Total Publications

Lifetime

7,955

Prior Five Years

1,134

Total Citations

Lifetime

113,668

Prior Five Years

6,511

Total Scholars

Lifetime

17,107

Prior Five Years

12,051

Institutional Rankings

Global (Worldwide)

Academic Institutions Lifetime		Academic Institutions Prior Five Years		Non-academic Institutions Lifetime
#1	University of Texas M.D. Anderson Cancer Center United States	#1	Shandong University China	#1	Dana-Farber Cancer Institute United States
#2	Leiden University Netherlands	#2	Henan University China	#2	Fred Hutchinson Cancer Research Center United States
#3	University of Montreal Canada	#3	University of California, Los Angeles United States	#3	Food and Drug Administration United States
#4	Wayne State University United States	#4	Vanderbilt University United States	#4	GlycoMimetics, Inc.
#5	Johns Hopkins University United States	#5	University of Colorado Anschutz Medical Campus United States	#5	Munich Leukemia Laboratory Germany
#6	Versailles Saint-Quentin-en-Yvelines University France	#6	University of Kansas United States	#6	Northwell Health United States
#7	University of Iowa United States	#7	University of Hamburg Germany	#7	Karolinska University Hospital Sweden
#8	Ludwig Maximilian University Of Munich Germany	#8	Augusta University United States	#8	Massachusetts General Hospital United States
#9	University of Washington United States	#9	Monash University Australia	#9	H. Lee Moffitt Cancer Center & Research Institute United States
#10	University of Kentucky United States		Show More	#10	Institut National de la Santé et de la Recherche Médicale France
	Show More				Show More

National Institutional Rankings

Publications and Citation History

Publications based on Disciplines

Scholars based on Disciplines

Publications based on Fields

Scholars based on Fields

Highly Ranked Scholars™

Lifetime

Prior Five Years

Evaluation Period:

Highly Cited Publications

Lifetime